Login to Your Account



U.S. Patent Disclosures


Friday, July 12, 2013
• Celldex Therapeutics Inc., of Needham, Mass., was issued U.S. Patent No. 8,481,029, "Human immune therapies using a CD27 agonist alone or in combination with other immune modulators." The patent covers its product candidate CDX-1127.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription